History of SARS-CoV-2 infection, anti-spike IgG antibody kinetics and neutralization capacities following the second and third dose of BNT162b2 vaccine in nursing home residents

Helene Jeulin; Carlos Labat; Kevin Duarte; Simon Toupance; Gregoire Nadin; Denis Craus; Ioannis Georgiopoulosh; Isabelle Gantois; Francois Goehringer; Athanase Benetos.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-22270557

Documentos relacionados

  1. Anti-spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents.
  2. [Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?]
  3. [Anti-flu Vaccine: tailor made solutions in large-scale distribution].
  4. [Factors Influencing Willingness to be Vaccinated with a COVID-19 Vaccine: Results of a CATI Population Survey].
  5. Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity.